Regulation
-
FDA seeks comments on expedited CNPV pilot program
The controversial Commissioner’s National Priorities Voucher program awards “ultra-fast” reviews for medications and biological products of strategic national importance while upholding the FDA’s standards.
-
SEC hints long-awaited e-delivery rule could be imminent
House lawmakers are also moving to allow electronic investor disclosures and communications, but the SEC may act first.
-
Rewriting fairness: The quiet power shift in UK financial redress
UK FOS overhaul is not a retreat from the politics of redress. It is a repositioning.
-
Your Canada update: Electronic trading rules, insider status, and more
CIRO offers guidance on how to notify the agency about third-party risk management control providers and when agreements with them are terminated.
-
Use of crypto as derivatives collateral outlined in CFTC factsheet
Guidance keeps limits on uncleared swaps, applies haircuts, and requires FCMs to meet reporting and operational requirements under a no-action pathway.
-
Bipartisan bill seeks to ban sports bets on prediction markets
The bill, “The Prediction Markets Are Gambling Act,” would clarify that, under US law, no CFTC-registered entity can list a contract that closely resembles a sports bet or a casino-style game.
-
Financial regulation 2.0: What EU regulatory evolution means for practitioners
Regulation targeting the financial sector continues to evolve. We explore the EU’s future approach, where reforms are balanced with core safeguards – alongside perspectives from other key markets for the Nordic and Baltic region.
-
FCA guidance on non-financial misconduct: What firms need to know before September 2026
Firms should take steps now to identify and mitigate NFM-related risks, including improving culture (a key driver of good conduct).